We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of a High Viscosity Dietary Fibre, as Part of a Medically Supervised Weight Management Program

This study has suspended participant recruitment.
(No grant funding yet for this trial.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01387126
First Posted: July 4, 2011
Last Update Posted: July 19, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
University of British Columbia
InovoBiologic Inc.
Information provided by (Responsible Party):
Canadian Center for Functional Medicine
  Purpose
The aim of this study is to investigate whether the supplementation of a medically supervised weight management program with a novel fibre supplement, improves body weight, body composition, and laboratory measurements in overweight and obese individuals. All subjects will participate in the medical weight management program however the intervention group will have 5 grams of a novel fibre supplemented to each meal while the control group will not.

Condition Intervention Phase
Obesity Dietary Supplement: Novel fibre supplement Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Randomized, Controlled Trial Evaluating the Effects of a High Viscosity Dietary Fibre, as Part of a Medically Supervised Weight Management Program, on Body Weight in Overweight and Obese Individuals

Resource links provided by NLM:


Further study details as provided by Canadian Center for Functional Medicine:

Primary Outcome Measures:
  • Body weight [ Time Frame: 52 weeks ]

Secondary Outcome Measures:
  • Body composition [ Time Frame: 52 weeks ]

Estimated Enrollment: 240
Arms Assigned Interventions
Experimental: Novel fibre supplement
The full dose of the study intervention is 15 grams per day.
Dietary Supplement: Novel fibre supplement
The full dose of the study intervention is 15 grams per day.
No Intervention: Weight management program

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 55 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • BMI 27 - 30 Kg/m2 with 1 weight-related comorbidity and/or BMI 30 - 50 Kg/m2
  • Ability to provide written informed consent in accordance with Good Clinical Practice (GCP) and local legislation in English

Exclusion Criteria:

  • Medications and supplements that affect body weight and appetite
  • Type 2 diabetes on insulin treatment
  • Contraindications to low calorie diet
  • Any allergies to study product ingredients
  • Any other medical, social or geographic condition, which, in the opinion of the investigator would not allow safe completion of the protocol.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01387126


Locations
Canada, British Columbia
Canadian Centre for Functional Medicine
Coquitlam, British Columbia, Canada, V7L1B5
Sponsors and Collaborators
Canadian Center for Functional Medicine
University of British Columbia
InovoBiologic Inc.
Investigators
Principal Investigator: Michael R Lyon, MD Canadian Centre for Functional Medicine
  More Information

Responsible Party: Canadian Center for Functional Medicine
ClinicalTrials.gov Identifier: NCT01387126     History of Changes
Other Study ID Numbers: 004
First Submitted: June 30, 2011
First Posted: July 4, 2011
Last Update Posted: July 19, 2017
Last Verified: July 2017